INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 23, 2012 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 1,532 |
| Feb 16, 2012 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Other acquisition or disposition | -- | -- | 4,264 |
| Feb 16, 2012 |
Director, EVP CSO President Regeneron Re
Trans History: 617
|
Director, EVP CSO President Regeneron Re | Form 4 | Other acquisition or disposition | -- | -- | 5,534 |
| Feb 15, 2012 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 84,773 |
| Feb 15, 2012 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,416 |
| Feb 15, 2012 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Feb 13, 2012 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 5 | Other acquisition or disposition | -- | -- | 40,087 |
| Feb 13, 2012 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 5 | Other acquisition or disposition | -- | -- | 100,000 |
| Feb 13, 2012 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 5 | Other acquisition or disposition | -- | -- | 2,271 |
| Feb 13, 2012 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 5 | Other acquisition or disposition | -- | -- | 94,222 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.